TRAIL STOP-LOSS TO 8900
WORLD MARKETS
US indices gained 1.4%-3%
on Friday after a report said a Gilead Sciences drug showed some effectiveness
in treating the coronavirus and countries around the world including the U.S.
and Germany are beginning to implement plans to lift lockdown measures as the
rate of new cases declines.
WTI crude for June expiry
fell 50 cents, or 2%, to $25.03 a barrel while Brent June contract rose 26
cents, or 0.9%, to $28.08. U.S. crude contract for May expiry tumbled $1.60, or
8.1%, to $18.27 per barrel, its lowest since January 2002, reflecting fears
over a global glut and tight storage space.
European market climbed
1.7%-3.4%. Euro zone inflation slowed sharply in March to 0.7% year-on-year,
down from 1.2% in February.
For the week, Nasdaq
climbed 6.1% while S & P 500 and Dow rose 3% and 2.2% respectively, all
extending the winning streak to second straight week and closing at the highest
level since early March. In Europe, FTSE and CAC fell 1% and 0.2% respectively
while DAX rose 0.6%. In Asia, Nikkei soared 13% while other markets ended with
modest gains ranging from 0.3%-1.7%. WTI crude plunged 22%, hitting an 18-year
low.
AT HOME
The week ended on a
positive note as Sensex and Nifty soared 3.2% and 3% respectively, extending
the winning streak to second straight day and closing at the highest level
since 13 March 2020. Sensex added 986 points to settle at 31588 while Nifty
finished at 9266, up 273 points. BSE mid-cap and small-cap indices gained 2.1%
and 2.4% respectively, extending rising streak to third straight day. Except 1%
and 0.7% lower FMCG and Healthcare indices respectively, all the BSE sectoral
indices ended higher with Bankex and Finance indices being the top gainers, up
6.8% and 5.4% respectively.
FIIs net sold stocks,
index futures and stock futures worth Rs 1392 cr, 7 cr and 729 cr respectively.
DIIs were net buyers to the tune of Rs 534 cr.
Rupee appreciated 47
paise to end at 76.39/$.
For the week, Sensex and
Nifty rose 1.4% and 1.7% respectively, extending winning streak to second straight
week.
RBI announced new
measures to boost liquidity, expand bank credit flow and ease financial stress. Targeted long-term repo operations (TLTRO) 2.0 worth ₹50,000 crore would be
conducted to benefit NBFCs and micro-financial institutions. The apex bank cut
reverse repo rate to 25 basis points to 3.75% so that banks are nudged to lend
more, instead of deploying funds with the central bank. Other measures include
providing Rs 50,000 crore refinance to Nabard, SIDBI and NHB and increasing the
ways and means advances (WMAs) limit to 60% to allow States the flexibility to
borrow. RBI also said the moratorium period will be excluded from the
classification of non-performing assets (NPAs).
HDFC Bank reported 17.7%
rise in Q4 net profit at Rs 6927 cr. NII rose 16.2% to Rs 15204 cr. Asset
quality improved on sequential basis. Gross NPA ratio improved to 1.26% from
1.42% while net NPA ratio improved to 0.36% from 0.48%. Provisions for
non-performing assets rose 24% q-o-q to Rs 3748 cr. Slippages came in at
10-quarter low.
OUTLOOK
Today morning, Hang Seng
and Shanghai are little changed while Nikkei is off 1%. SGX Nifty is suggesting
about 50 points lower start for our market.
At the risk of repeating,
we had advised going long on Nifty after 8678 hurdle was taken out on 7th April
and have been advising holding on to long positions with a trailing stop-loss.
On Friday, we had
reiterated the target of 9390 and had advised trailing the stop-loss to 8800.
Nifty, on Friday, touched
a high of 9324 before closing at 9266 and is set to open near 9200 today.
9390, the the 38.2%
retracement level of the entire 12430-7511 fall, continues to be next target/ resistance to eye. Above 9390,
34-DMA, placed around 9500, would be the next important target/resistance.
On the way down, 8900, where a trendline adjoining recent bottoms
on the hourly chart is placed, is the immediate support, with the stop-loss of
which, existing longs can be held on to.
Infosys will report its
quarterly earnings today.
No comments:
Post a Comment